BR112022017713A2 - Métodos e composições para modular um genoma - Google Patents

Métodos e composições para modular um genoma

Info

Publication number
BR112022017713A2
BR112022017713A2 BR112022017713A BR112022017713A BR112022017713A2 BR 112022017713 A2 BR112022017713 A2 BR 112022017713A2 BR 112022017713 A BR112022017713 A BR 112022017713A BR 112022017713 A BR112022017713 A BR 112022017713A BR 112022017713 A2 BR112022017713 A2 BR 112022017713A2
Authority
BR
Brazil
Prior art keywords
compositions
methods
genome
modulate
modulating
Prior art date
Application number
BR112022017713A
Other languages
English (en)
Inventor
Ethan Steinberg Barrett
Helen Bothmer Anne
Edward Salomon William
Shcherbakova Inna
Giovanna Silvia Cotta-Ramusino Cecilia
Rosenblum Rubens Jacob
James Citorik Robert
Jun Wang Zi
Original Assignee
Flagship Pioneering Innovations Vi Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flagship Pioneering Innovations Vi Llc filed Critical Flagship Pioneering Innovations Vi Llc
Publication of BR112022017713A2 publication Critical patent/BR112022017713A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Toys (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

MÉTODOS E COMPOSIÇÕES PARA MODULAR UM GENOMA. A presente invenção refere-se a métodos e composições para modular um genoma-alvo.
BR112022017713A 2020-03-04 2021-03-04 Métodos e composições para modular um genoma BR112022017713A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062985291P 2020-03-04 2020-03-04
US202063035638P 2020-06-05 2020-06-05
PCT/US2021/020933 WO2021178709A1 (en) 2020-03-04 2021-03-04 Methods and compositions for modulating a genome

Publications (1)

Publication Number Publication Date
BR112022017713A2 true BR112022017713A2 (pt) 2022-11-16

Family

ID=77612784

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022017713A BR112022017713A2 (pt) 2020-03-04 2021-03-04 Métodos e composições para modular um genoma

Country Status (7)

Country Link
US (1) US20230242899A1 (pt)
EP (1) EP4114940A1 (pt)
JP (1) JP2023516692A (pt)
AU (1) AU2021232005A1 (pt)
BR (1) BR112022017713A2 (pt)
CA (1) CA3174537A1 (pt)
WO (1) WO2021178709A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3592853A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Suppression of pain by gene editing
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
US11319532B2 (en) 2017-08-30 2022-05-03 President And Fellows Of Harvard College High efficiency base editors comprising Gam
WO2020191153A2 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
WO2021046243A2 (en) 2019-09-03 2021-03-11 Myeloid Therapeutics, Inc. Methods and compositions for genomic integration
RU2724470C1 (ru) * 2019-11-11 2020-06-23 Автономная некоммерческая образовательная организация высшего образования Сколковский институт науки и технологий Применение cas9 белка из бактерии pasteurella pneumotropica для модификации геномной днк в клетках
KR20230019843A (ko) 2020-05-08 2023-02-09 더 브로드 인스티튜트, 인코퍼레이티드 표적 이중 가닥 뉴클레오티드 서열의 두 가닥의 동시 편집을 위한 방법 및 조성물
CN118103500A (zh) * 2021-10-15 2024-05-28 科德克希思公司 重组逆转录酶变体
US20230272434A1 (en) * 2021-10-19 2023-08-31 Massachusetts Institute Of Technology Genomic editing with site-specific retrotransposons
WO2023091987A2 (en) * 2021-11-19 2023-05-25 Emendobio Inc. Omni 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286,287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307,308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325,326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345,346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364,365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, 377, 378, 380, 381, 382, 383, 384, 385, and 386 crispr nucleases
US11866728B2 (en) 2022-01-21 2024-01-09 Renagade Therapeutics Management Inc. Engineered retrons and methods of use
WO2023141602A2 (en) * 2022-01-21 2023-07-27 Renagade Therapeutics Management Inc. Engineered retrons and methods of use
WO2024044723A1 (en) * 2022-08-25 2024-02-29 Renagade Therapeutics Management Inc. Engineered retrons and methods of use
WO2024077267A1 (en) * 2022-10-07 2024-04-11 The Broad Institute, Inc. Prime editing methods and compositions for treating triplet repeat disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017201579A1 (en) * 2016-05-27 2017-11-30 Griffith University Arthrogenic alphavirus vaccine
WO2020047124A1 (en) * 2018-08-28 2020-03-05 Flagship Pioneering, Inc. Methods and compositions for modulating a genome

Also Published As

Publication number Publication date
WO2021178709A1 (en) 2021-09-10
CA3174537A1 (en) 2021-09-10
JP2023516692A (ja) 2023-04-20
US20230242899A1 (en) 2023-08-03
AU2021232005A1 (en) 2022-09-29
EP4114940A1 (en) 2023-01-11

Similar Documents

Publication Publication Date Title
BR112022017715A2 (pt) Métodos e composições para modular um genoma
BR112022017713A2 (pt) Métodos e composições para modular um genoma
BR112022017736A2 (pt) Métodos e composições aprimorados para modular um genoma
BR112021024224A2 (pt) Inibidores de tead e usos dos mesmos
CO2021006098A2 (es) Moduladores de profármacos de la vía de estrés integrada
CO2020006248A2 (es) Moduladores de la vía de estrés integrada
BR112021024108A2 (pt) Inibidores de tead e usos dos mesmos
CO2021015668A2 (es) Moduladores de la vía integrada del estrés
MX2020004538A (es) Moduladores de la vía de estrés integrada.
MX2020004534A (es) Moduladores de la vía integrada del estrés.
ECSP20027553A (es) Moduladores de la vía de estrés integrada
CO2018012946A2 (es) Moduladores de la vía de estrés integrada
MX2020004557A (es) Moduladores de la vía de estrés integrada.
MX2020004537A (es) Moduladores de la vía integrada del estrés.
BR112022003970A2 (pt) Métodos e composições para integração genômica
BR112018008227A2 (pt) ?composto, composição, e, métodos para inibir acc, para tratar um distúrbio metabólico, um câncer ou outro distúrbio proliferativo, uma infecção fúngica, parasítica ou bacteriana e para controlar patógenos fúngicos agrícolas?
BR112021026220A2 (pt) Edição aprimorada do genoma por reparo dependente de homologia
BR112019016635A2 (pt) aminotriazolopiridinas como inibidores da cinase
ECSP13012590A (es) Composiciones bioactivas de chromobacterium y metabolitos
WO2021102390A8 (en) Recombinase compositions and methods of use
BR112022017089A2 (pt) Derivados de piridazina para modular o splicing de ácido nucleico
BR112021023144A2 (pt) Compostos de oxatiazina para inibir gapdh
BR112023022298A2 (pt) Moduladores de trex1
BR112021017159A2 (pt) Supressão da expressão de gene alvo através da edição de genoma de mirnas nativos
BR112022003512A2 (pt) Sistema para regular expressão gênica